Tofacitinib
20210918pss
Phase 2 small_molecule active
Quick answer
Tofacitinib for Primary Sjögren's Syndrome is a Phase 2 program (small_molecule) at Peking University People's Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Peking University People's Hospital
- Indication
- Primary Sjögren's Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active